Cargando…
Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959341/ https://www.ncbi.nlm.nih.gov/pubmed/35355554 http://dx.doi.org/10.3389/fendo.2022.868174 |
_version_ | 1784677132166758400 |
---|---|
author | Wang, Renzhi Zhou, Cuiqi McCormack, Ann I. Mamelak, Adam N. |
author_facet | Wang, Renzhi Zhou, Cuiqi McCormack, Ann I. Mamelak, Adam N. |
author_sort | Wang, Renzhi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8959341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89593412022-03-29 Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments Wang, Renzhi Zhou, Cuiqi McCormack, Ann I. Mamelak, Adam N. Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2022-03-09 /pmc/articles/PMC8959341/ /pubmed/35355554 http://dx.doi.org/10.3389/fendo.2022.868174 Text en Copyright © 2022 Wang, Zhou, McCormack and Mamelak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wang, Renzhi Zhou, Cuiqi McCormack, Ann I. Mamelak, Adam N. Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title | Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title_full | Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title_fullStr | Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title_full_unstemmed | Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title_short | Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments |
title_sort | editorial: refractory pituitary adenoma—current challenges and emerging treatments |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959341/ https://www.ncbi.nlm.nih.gov/pubmed/35355554 http://dx.doi.org/10.3389/fendo.2022.868174 |
work_keys_str_mv | AT wangrenzhi editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments AT zhoucuiqi editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments AT mccormackanni editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments AT mamelakadamn editorialrefractorypituitaryadenomacurrentchallengesandemergingtreatments |